Ob/Gyn Department Meeting: Fetal Fibronectin and Prediction of Preterm Delivery
Preterm birth is an important cause of perinatal morbidity and mortality. Various biomarkers in cervicovaginal secretions related to preterm birth have been investigated, of which fetal fibronectin (fFN) shows the greatest potential because of its high negative predictive value. Accurate prediction of the risk of spontaneous preterm birth is crucial for the clinical management of patients with preterm labor. The identification of women truly in preterm labor allows appropriate application of interventions that can improve neonatal outcome.
Obstetricians and Gynecologists
- Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients.
- Implement strategies utilizing fFN to more accurately identify patients in preterm labor.
- Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women.
- Apply management strategies and interventions for preterm birth to improve clinical outcomes.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Nurse Practitioners
- 1.00 General certificate of attendance